SCHULMAN AMY W has filed 18 insider transactions across 3 companies since February 2024.
Most recent transaction: a sale of 26 shares of Elevance Health, Inc. ($ELV) on March 12, 2026.
Activity breakdown: 1 open-market purchase and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | Elevance Health, Inc. | $ELV | SCHULMAN AMY W | Director | S | Common Stock | 26 | $287.50 | 218.0000 | 224,600,000 | 10.66% | 0.00% |
| Feb. 2, 2026 | Elevance Health, Inc. | $ELV | SCHULMAN AMY W | Director | A | Common Stock | 218 | $0.00 | 218.0000 | 224,600,000 | 9999.99% | 0.00% |
| June 11, 2025 | FRACTYL HEALTH, INC. | $GUTS | SCHULMAN AMY W | Not found | A | Stock Option | 22500 | $0.00 | 22,500.0000 | 48,920,221 | 9999.99% | 0.05% |
| May 8, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SCHULMAN AMY W | Director | A | Common Stock | 775 | $0.00 | 11,961.0000 | 127,651,000 | 6.93% | 0.00% |
| May 8, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SCHULMAN AMY W | Director | A | Stock Option (right to buy) | 1558 | $0.00 | 1,558.0000 | 127,651,000 | 9999.99% | 0.00% |
| March 13, 2025 | FRACTYL HEALTH, INC. | $GUTS | SCHULMAN AMY W | Not found | P | Common Stock | 8550 | $1.17 | 8,550.0000 | 48,920,221 | 9999.99% | 0.02% |
| March 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SCHULMAN AMY W | Director | M | Stock Option (right to buy) | 2750 | $0.00 | 0.0000 | 127,651,000 | 100.00% | 0.00% |
| March 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SCHULMAN AMY W | Director | M | Common Stock | 2750 | $131.21 | 11,186.0000 | 127,651,000 | 32.60% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SCHULMAN AMY W | Director | S | Common Stock | 8500 | $240.00 | 8,436.0000 | 124,906,000 | 50.19% | 0.01% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SCHULMAN AMY W | Director | M | Stock Option (right to buy) | 8500 | $0.00 | 2,750.0000 | 124,906,000 | 75.56% | 0.01% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SCHULMAN AMY W | Director | M | Common Stock | 8500 | $131.21 | 16,936.0000 | 124,906,000 | 100.76% | 0.01% |
| May 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SCHULMAN AMY W | Director | M | Stock Option (right to buy) | 30000 | $0.00 | 0.0000 | 124,906,000 | 100.00% | 0.02% |
| May 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SCHULMAN AMY W | Director | S | Common Stock | 11516 | $148.93 | 8,499.0000 | 124,906,000 | 57.54% | 0.01% |
| May 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SCHULMAN AMY W | Director | S | Common Stock | 63 | $149.76 | 8,436.0000 | 124,906,000 | 0.74% | 0.00% |
| May 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SCHULMAN AMY W | Director | S | Common Stock | 10121 | $148.21 | 20,015.0000 | 124,906,000 | 33.58% | 0.01% |
| May 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SCHULMAN AMY W | Director | M | Common Stock | 30000 | $66.83 | 30,136.0000 | 124,906,000 | 9999.99% | 0.02% |
| May 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | SCHULMAN AMY W | Director | A | Stock Option (right to buy) | 5228 | $0.00 | 5,228.0000 | 124,906,000 | 9999.99% | 0.00% |
| Feb. 1, 2024 | FRACTYL HEALTH, INC. | $GUTS | SCHULMAN AMY W | Not found | A | Stock Option | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |